Payment overview · 2025
General Payments
$59.40
3 reported records · 1 companies
Healthcare provider profile · identity verified
Lisa E Ceraolo, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TOWANDA, PA · NPI 1326264383
Verified facts
What the public records show
CMS Open Payments records show Lisa E Ceraolo, MD received $59.40 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 122 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $59.40 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $59.40 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $59.40 | 3 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $33.48 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 122 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
122 | 26 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 709 | 183 |
| Levothyroxine Sodium | Levothyroxine Sodium | 686 | 168 |
| Omeprazole | Omeprazole | 620 | 144 |
| Atorvastatin Calcium | Atorvastatin Calcium | 611 | 177 |
| Lisinopril | Lisinopril | 570 | 161 |
| Amlodipine Besylate | Amlodipine Besylate | 440 | 134 |
| Metoprolol Succinate | Metoprolol Succinate | 415 | 116 |
| Gabapentin | Gabapentin | 409 | 119 |
| Metformin Hcl Er | Metformin Hcl | 402 | 99 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 343 | 99 |
| Pantoprazole Sodium | Pantoprazole Sodium | 331 | 82 |
| Glipizide Er | Glipizide | 308 | 69 |
| Simvastatin | Simvastatin | 304 | 87 |
| Tamsulosin Hcl | Tamsulosin Hcl | 292 | 66 |
| Losartan Potassium | Losartan Potassium | 274 | 68 |
| Furosemide | Furosemide | 273 | 91 |
| Eliquis | Apixaban | 267 | 47 |
| Prednisone | Prednisone | 249 | 160 |
| Metformin Hcl | Metformin Hcl | 228 | 63 |
| Escitalopram Oxalate | Escitalopram Oxalate | 213 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 213 | 55 |
| Allopurinol | Allopurinol | 210 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 208 | 54 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 166 | 40 |
| Trazodone Hcl | Trazodone Hcl | 154 | 44 |
| Montelukast Sodium | Montelukast Sodium | 145 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 144 | 32 |
| Diclofenac Sodium | Diclofenac Sodium | 142 | 30 |
| Sertraline Hcl | Sertraline Hcl | 134 | 35 |
| Tramadol Hcl | Tramadol Hcl | 133 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 130 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 130 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 127 | 48 |
| Ozempic | Semaglutide | 122 | 26 |
| Xarelto | Rivaroxaban | 120 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 119 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 118 | 17 |
| Spironolactone | Spironolactone | 117 | 37 |
| Potassium Chloride | Potassium Chloride | 116 | 25 |
| Meloxicam | Meloxicam | 112 | 27 |
| Azithromycin | Azithromycin | 111 | 68 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 109 | 20 |
| Atenolol | Atenolol | 106 | 29 |
| Famotidine | Famotidine | 106 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 105 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 100 | 21 |
| Clonazepam | Clonazepam | 98 | 12 |
| Trulicity | Dulaglutide | 97 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 96 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 93 | 24 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 93 | 19 |
| Lorazepam | Lorazepam | 89 | 22 |
| Alendronate Sodium | Alendronate Sodium | 88 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 88 | 19 |
| Liothyronine Sodium | Liothyronine Sodium | 86 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 81 | 18 |
| Donepezil Hcl | Donepezil Hcl | 75 | 18 |
| Buspirone Hcl | Buspirone Hcl | 74 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 74 | 52 |
| Valsartan | Valsartan | 72 | 20 |
| Ibuprofen | Ibuprofen | 68 | 18 |
| Torsemide | Torsemide | 68 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 67 | 18 |
| Ezetimibe | Ezetimibe | 67 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 66 | 13 |
| Jardiance | Empagliflozin | 65 | 17 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 63 | 62 |
| Benazepril Hcl | Benazepril Hcl | 60 | 18 |
| Januvia | Sitagliptin Phosphate | 58 | 13 |
| Carvedilol | Carvedilol | 56 | 18 |
| Alprazolam | Alprazolam | 55 | 15 |
| Ramipril | Ramipril | 55 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 54 | 13 |
| Meclizine Hcl | Meclizine Hcl | 54 | 23 |
| Naproxen | Naproxen | 54 | 16 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 53 | suppressed |
| Bupropion Xl | Bupropion Hcl | 52 | 15 |
| Celecoxib | Celecoxib | 52 | 13 |
| Cephalexin | Cephalexin | 52 | 35 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 52 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 52 | 14 |
| Mirtazapine | Mirtazapine | 51 | 14 |
| Nifedipine Er | Nifedipine | 51 | 15 |
| Methocarbamol | Methocarbamol | 50 | 18 |
| Finasteride | Finasteride | 49 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 47 | 13 |
| Clonidine Hcl | Clonidine Hcl | 46 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 21 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 42 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | 15 |
| Gemfibrozil | Gemfibrozil | 40 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | 24 |
| Nitroglycerin | Nitroglycerin | 38 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 37 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 37 | suppressed |
| Sucralfate | Sucralfate | 37 | 13 |
| Labetalol Hcl | Labetalol Hcl | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | 12 |
| Primidone | Primidone | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Fluconazole | Fluconazole | 35 | 25 |
| Linzess | Linaclotide | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Phenobarbital | Phenobarbital | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 33 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Levetiracetam | Levetiracetam | 32 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 31 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Klor-Con M20 | Potassium Chloride | 30 | 12 |
| Pregabalin | Pregabalin | 30 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Baclofen | Baclofen | 29 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 24 |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Nystatin | Nystatin | 28 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 28 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | 17 |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Ondansetron Odt | Ondansetron | 25 | 17 |
| Ibandronate Sodium | Ibandronate Sodium | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 20 |
| Verapamil Sr | Verapamil Hcl | 22 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 21 | 12 |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Lidocaine | Lidocaine | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 17 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 17 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 16 | 11 |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 14 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Cabergoline | Cabergoline | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 11 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Dapsone | Dapsone | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Mydayis | Dextroamphetamine/Amphetamine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $59.40 · 3 records | Novo Nordisk Inc | Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error